{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:50Z","timestamp":1783350950512,"version":"3.54.6"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2021CXA031"],"award-info":[{"award-number":["2021CXA031"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Alternative splicing (AS) and RNA-binding proteins (RBPs) have been implicated in various diseases. However, a comprehensive understanding of their role in RNA metabolism, progression, and metastasis in cervical cancer remains elusive. This study aimed to identify the potential effect of zinc finger CCCH-type containing 18 (ZC3H18) in cervical cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Gene Expression Omnibus (GEO) dataset (GSE94427) was used to analyze the expression level of ZC3H18 in HeLa cells and its regulated alternative splicing events (ASEs). The Cancer Genome Atlas (TCGA) cervical cancer dataset and in vitro experiments were used for verification. The signaling pathways and functions of ZC3H18-regulated ASEs were investigated through enrichment analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Knockdown of ZC3H18 in HeLa cells increased the expression of 106 genes but decreased the expression of 226 genes. ZC3H18 was found to be involved in the regulation of 1,830 ASEs. The AS genes were enriched in cervical cancer-related signaling pathways. Validation using 39 cervical cancer samples from the TCGA database showed that 20 cases had low ZC3H18 expression and 19 had high expression. By integrating GEO and TCGA datasets along with in vitro experiments, 18 ASEs with consistent changes were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study demonstrated that ZC3H18 extensively regulates AS of cancer-associated pathways in HeLa cells and cervical cancer tissues. The identification of ZC3H18-regulated ASEs may provide potential targets for cervical cancer treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1621238","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:21:16Z","timestamp":1757391676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["ZC3H18 regulates alternative splicing and related genes in cervical cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenjuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103178","DOI":"10.1016\/j.critrevonc.2020.103178","article-title":"Molecular landscape of recurrent cervical cancer","volume":"157","author":"Adiga","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1261\/rna.057919.116","article-title":"Splicing-factor alterations in cancers","volume":"22","author":"Anczuk\u00f3w","year":"2016","journal-title":"Rna"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nsmb.2703","article-title":"The human cap-binding complex is functionally connected to the nuclear RNA exosome","volume":"20","author":"Andersen","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review","author":"Caruso","year":"2025","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/mc.23477","article-title":"Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5","volume":"62","author":"Che","year":"2023","journal-title":"Mol. Carcinog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1093\/nar\/gku350","article-title":"A sub-element in PRE enhances nuclear export of intronless mRNAs by recruiting the TREX complex via ZC3H18","volume":"42","author":"Chi","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcv.2018.01.016","article-title":"Continuing global improvement in human papillomavirus DNA genotyping services: the 2013 and 2014 HPV LabNet international proficiency studies","volume":"101","author":"Eklund","year":"2018","journal-title":"J. Clin. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jmv.21406","article-title":"Increased expression of cellular RNA-Binding proteins in HPV-Induced neoplasia and cervical cancer","volume":"81","author":"Fay","year":"2009","journal-title":"J. Med. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1073\/pnas.1120542109","article-title":"Genome-wide siRNA screen for mediators of NF-\u03baB activation","volume":"109","author":"Gewurz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.celrep.2017.02.046","article-title":"Mutually exclusive CBC-containing complexes contribute to RNA fate","volume":"18","author":"Giacometti","year":"2017","journal-title":"Cell Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-Binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12935-021-02319-7","article-title":"Expression profile of RNA binding protein in cervical cancer using bioinformatics approach","volume":"21","author":"Huang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.molcel.2011.02.003","article-title":"Identification of an mRNP complex regulating tumorigenesis at the translational elongation step","volume":"41","author":"Hussey","year":"2011","journal-title":"Mol. Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1093\/nar\/gkx647","article-title":"ARS2 is a general suppressor of pervasive transcription","volume":"45","author":"Iasillo","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1158\/1535-7163.MCT-13-0572","article-title":"Low levels of circulating estrogen sensitize PTEN-Null endometrial tumors to PARP inhibition in vivo","volume":"12","author":"Janzen","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12905-025-03612-7","article-title":"Efficacy comparison of PD-1\/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis","volume":"25","author":"Ji","year":"2025","journal-title":"BMC Womens Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12864-017-3507-y","article-title":"Transcriptome analysis reveals the complexity of alternative splicing regulation in the fungus verticillium dahliae","volume":"18","author":"Jin","year":"2017","journal-title":"BMC Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","article-title":"Comprehensive analysis of alternative splicing across tumors from 8,705 patients","volume":"34","author":"Kahles","year":"2018","journal-title":"Cancer Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1038\/s41467-019-12610-x","article-title":"ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer","volume":"10","author":"Kanakkanthara","year":"2019","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-Genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/life11080746","article-title":"CXCR3 expression and genome-wide 3' splice site selection in the TCGA breast cancer cohort","volume":"11","author":"Levesque","year":"2021","journal-title":"Life (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41388-017-0119-6","article-title":"SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-\u03baB-CD47 axis","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00109-022-02257-5","article-title":"Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression","volume":"100","author":"Liu","year":"2022","journal-title":"J. Mol. Med. Berl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"15585","DOI":"10.3390\/ijms232415585","article-title":"The VEGF\/VEGFR axis revisited: implications for cancer therapy","volume":"23","author":"Mabeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrm1645","article-title":"Understanding alternative splicing: towards a cellular code","volume":"6","author":"Matlin","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0102-13","article-title":"A genomic view of alternative splicing","volume":"30","author":"Modrek","year":"2002","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nsmb.2751","article-title":"Good cap\/bad cap: how the cap-binding complex determines RNA fate","volume":"21","author":"M\u00fcller-McNicoll","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/biomedicines13071525","article-title":"Management of advanced ovarian cancer: current clinical practice and future perspectives","volume":"13","author":"Papageorgiou","year":"2025","journal-title":"Biomedicines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ymthe.2021.11.010","article-title":"Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2005.05.026","article-title":"Regulation of apoptosis by alternative pre-mRNA splicing","volume":"19","author":"Schwerk","year":"2005","journal-title":"Mol. Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ebiom.2018.11.007","article-title":"SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance","volume":"38","author":"Sheng","year":"2018","journal-title":"EBioMedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2017.09.018","article-title":"Alternative splicing in cancers: from aberrant regulation to new therapeutics","volume":"75","author":"Song","year":"2018","journal-title":"Seminars Cell and Dev. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.1160342","article-title":"A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome","volume":"321","author":"Sultan","year":"2008","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/07853899909115976","article-title":"New concepts on the role of human papillomavirus in cell cycle regulation","volume":"31","author":"Syrj\u00e4nen","year":"1999","journal-title":"Ann. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","article-title":"The role of the E6-p53 interaction in the molecular pathogenesis of HPV","volume":"18","author":"Thomas","year":"1999","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1476","DOI":"10.1002\/wrna.1476","article-title":"Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics","volume":"9","author":"Urbanski","year":"2018","journal-title":"Wiley Interdiscip. Reviews-Rna"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1158\/0008-5472.CAN-16-0186","article-title":"The BRCA1-\u039411q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.celrep.2017.12.037","article-title":"Characterizing ZC3H18, a multi-domain protein at the interface of RNA production and destruction decisions","volume":"22","author":"Winczura","year":"2018","journal-title":"Cell Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bbagrm.2017.07.004","article-title":"CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells","volume":"1860","author":"Xia","year":"2017","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"B43","doi-asserted-by":"publisher","first-page":"W316","DOI":"10.1093\/nar\/gkr483","article-title":"KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases","volume":"39","author":"Xie","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"40488","DOI":"10.1038\/srep40488","article-title":"Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1039\/d1fo03542h","article-title":"The natural compound neobractatin inhibits cell proliferation mainly by regulating the RNA binding protein CELF6","volume":"13","author":"Zheng","year":"2022","journal-title":"Food Funct."},{"key":"B47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-020-01167-9","article-title":"PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1621238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:21:18Z","timestamp":1757391678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1621238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":47,"alternative-id":["10.3389\/fgene.2025.1621238"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1621238","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"article-number":"1621238"}}